Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1990 Oct;53(10):821–823. doi: 10.1136/jnnp.53.10.821

Risk factors for multiple sclerosis: race or place?

A Compston
PMCID: PMC488239  PMID: 2266359

Full text

PDF
821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bharucha N. E., Bharucha E. P., Wadia N. H., Singhal B. S., Bharucha A. E., Bhise A. V., Kurtzke J. F., Schoenberg B. S. Prevalence of multiple sclerosis in the Parsis of Bombay. Neurology. 1988 May;38(5):727–729. doi: 10.1212/wnl.38.5.727. [DOI] [PubMed] [Google Scholar]
  2. Cook S. D., MacDonald J., Tapp W., Poskanzer D., Dowling P. C. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand. 1988 Feb;77(2):148–151. doi: 10.1111/j.1600-0404.1988.tb05885.x. [DOI] [PubMed] [Google Scholar]
  3. Dean G. Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Br Med J. 1967 Jun 17;2(5554):724–730. doi: 10.1136/bmj.2.5554.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ebers G. C., Bulman D. E., Sadovnick A. D., Paty D. W., Warren S., Hader W., Murray T. J., Seland T. P., Duquette P., Grey T. A population-based study of multiple sclerosis in twins. N Engl J Med. 1986 Dec 25;315(26):1638–1642. doi: 10.1056/NEJM198612253152603. [DOI] [PubMed] [Google Scholar]
  5. Hammond S. R., McLeod J. G., Millingen K. S., Stewart-Wynne E. G., English D., Holland J. T., McCall M. G. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain. 1988 Feb;111(Pt 1):1–25. doi: 10.1093/brain/111.1.1. [DOI] [PubMed] [Google Scholar]
  6. Koren G., Butt W., Rajchgot P., Mayer J., Whyte H., Pape K., MacLeod S. M. Intravenous paraldehyde for seizure control in newborn infants. Neurology. 1986 Jan;36(1):108–111. doi: 10.1212/wnl.36.1.108. [DOI] [PubMed] [Google Scholar]
  7. Kurtzke J. F. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand. 1975 Feb;51(2):110–136. doi: 10.1111/j.1600-0404.1975.tb01364.x. [DOI] [PubMed] [Google Scholar]
  8. Kurtzke J. F., Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology. 1986 Mar;36(3):307–328. doi: 10.1212/wnl.36.3.307. [DOI] [PubMed] [Google Scholar]
  9. Leibowitz U., Kahana E., Alter M. The changing frequency of multiple sclerosis in Israel. Arch Neurol. 1973 Aug;29(2):107–110. doi: 10.1001/archneur.1973.00490260051010. [DOI] [PubMed] [Google Scholar]
  10. Matsushita S., Morimoto C., Schlossman S. F., Sasazuki T. Monoclonal antibody 4B4 blocks suppression of the immune response to Cryptomeria japonica pollen antigen. Hum Immunol. 1988 May;22(1):1–7. doi: 10.1016/0198-8859(88)90046-8. [DOI] [PubMed] [Google Scholar]
  11. Miller D. H., Hornabrook R. W., Dagger J., Fong R. Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand. J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):43–46. doi: 10.1136/jnnp.49.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Oksenberg J. R., Stuart S., Begovich A. B., Bell R. B., Erlich H. A., Steinman L., Bernard C. C. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature. 1990 May 24;345(6273):344–346. doi: 10.1038/345344a0. [DOI] [PubMed] [Google Scholar]
  13. SUTHERLAND J. M. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain. 1956 Dec;79(4):635–654. doi: 10.1093/brain/79.4.635. [DOI] [PubMed] [Google Scholar]
  14. Seboun E., Robinson M. A., Doolittle T. H., Ciulla T. A., Kindt T. J., Hauser S. L. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 1989 Jun 30;57(7):1095–1100. doi: 10.1016/0092-8674(89)90046-9. [DOI] [PubMed] [Google Scholar]
  15. Shepherd D. I., Downie A. W. Prevalence of multiple sclerosis in north-east Scotland. Br Med J. 1978 Jul 29;2(6133):314–316. doi: 10.1136/bmj.2.6133.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Skegg D. C., Corwin P. A., Craven R. S., Malloch J. A., Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):134–139. doi: 10.1136/jnnp.50.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Swingler R. J., Compston D. A. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1520–1524. doi: 10.1136/jnnp.51.12.1520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Swingler R. J., Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1115–1124. doi: 10.1136/jnnp.49.10.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams E. S., McKeran R. O. Prevalence of multiple sclerosis in a south London borough. Br Med J (Clin Res Ed) 1986 Jul 26;293(6541):237–239. doi: 10.1136/bmj.293.6541.237. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES